C21 · Pharmaceuticals · 4 regions

Clinical trial country use share

European Union: 27% in 2025.

  • 27% Latest · European Union · 2025
  • Annual Release cadence
  • 10 Records · 4 regions · 2019–2025

Verified 27 Sep 2026 · 1 publisher · Next period 2026

Across regions

3 regions on one axis, spaced by time. Below it, selected latest values by region. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.

Fig 1 · C21 · 4 regions Annual

Clinical trial country use share by region

3 of 4 regions drawn, 2019 to 2025; latest values are ranked below

3 regions · 8 observations · 2019 to 2025

No figure published for these periods

Clinical trial country use share by regionClinical trial country use share by region. 3 regions on one axis: European Union, North America, China. 8 observations from 2019 to 2025, ranging from 10% to 32%. Latest values: European Union 27% (2025); North America 23% (2023); China 15% (2023). % 0 10 20 30 40 2019 2020 2021 2022 2023 2024 2025 European Union North America China
Clinical trial country use share by regionClinical trial country use share by region. 3 regions on one axis: European Union, North America, China. 8 observations from 2019 to 2025, ranging from 10% to 32%. Latest values: European Union 27% (2025); North America 23% (2023); China 15% (2023). % 0 10 20 30 40 2019 2020 2021 2022 2023 2024 2025 European Union North America China
Clinical trial country use share by regionClinical trial country use share by region. 3 regions on one axis: European Union, North America, China. 8 observations from 2019 to 2025, ranging from 10% to 32%. Latest values: European Union 27% (2025); North America 23% (2023); China 15% (2023). % 0 10 20 30 40 2019 2020 2021 2022 2023 2024 2025 European Union North America China
View the underlying data
Clinical trial country use share by region
Region Period Type Value
European Union 2025 Actual 27%
European Union 2023 Actual 25%
European Union 2019 Actual 32%
North America 2023 Actual 23%
North America 2019 Actual 19%
China 2023 Actual 15%
China 2021–2023 Actual 13%
China 2019 Actual 10%
Source: IQVIA · percent · CC BY 4.0 · statorigin.org
Fig 2 · C21 · Latest by region

Clinical trial country use share by region

Latest value per region, periods differ

4 entries

Latest available period per row; periods differ

Clinical trial country use share by regionClinical trial country use share by region. 4 categories, highest is European Union at 27%. Bars refer to different periods; each is labelled with its own. China 2023 United States 2021–2023 North America 2023 European Union 2025 15% 16% 23% 27%
Clinical trial country use share by regionClinical trial country use share by region. 4 categories, highest is European Union at 27%. Bars refer to different periods; each is labelled with its own. China 2023 United States 2021–2023 North America 2023 European Union 2025 15% 16% 23% 27%
Clinical trial country use share by regionClinical trial country use share by region. 4 categories, highest is European Union at 27%. Bars refer to different periods; each is labelled with its own. China 2023 United States 2021–2023 North America 2023 European Union 2025 15% 16% 23% 27%
View the underlying data
Clinical trial country use share by region
Category Period Source Type Value
European Union 2025 IQVIA Actual 27%
North America 2023 IQVIA Actual 23%
United States 2021–2023 IQVIA Actual 16%
China 2023 IQVIA Actual 15%
Source: IQVIA · percent · CC BY 4.0 · statorigin.org

Latest available period per row; years differ.

Every record

10 records · 4 regions · 2019–2025. Each period links to its record: the value, its source evidence and original document.

Clinical trial country use share: every record, grouped by region, newest first.
Period Value Source Type
European Union 4 records
2025 27% IQVIA · 31 Dec 2025
2025 27% IQVIA · 31 Dec 2025
2023 25% IQVIA · 31 Dec 2023
2019 32% IQVIA · 31 Dec 2019
North America 2 records
2023 23% IQVIA · 31 Dec 2023
2019 19% IQVIA · 31 Dec 2019
United States 1 record
2021–2023 16% IQVIA · 31 Dec 2023
China 3 records
2023 15% IQVIA · 31 Dec 2023
2021–2023 13% IQVIA · 31 Dec 2023
2019 10% IQVIA · 31 Dec 2019

Download this data

Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: IQVIA. Licence: CC BY 4.0.

Embed this chart

For automatic sizing and multiple charts, see the JavaScript embed guide.

Free to embed anywhere, including commercially. The attribution bar is part of the chart. The link under the frame is optional: keep it, remove it or mark it rel="nofollow".

<iframe src="https://statorigin.org/embed/pharmaceuticals--clinical-trial-country-use-share--regions" width="100%" height="380" style="border:1px solid #e2e5e3;border-radius:8px" title="Clinical trial country use share by region" loading="lazy"></iframe>
<p><a href="https://statorigin.org/indicators/clinical-trial-country-use-share">Data: IQVIA via StatOrigin</a> · CC BY 4.0</p>
Preview embed

Use and publication rights

  • View, cite and link: free

    Quote any number, cite this page or a single record, and link to it anywhere.

  • Copy, chart and republish: free with attribution

    The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (IQVIA); the chart files already carry that line.

  • The source documents: the publisher's terms

    Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.

How this measure is built

Definition
Percentage of total clinical trial country uses accounted for by a given region.
Measure
One slice of Clinical trial country uses ( form: share ) . Total number of country participations across clinical trials. Region and period are columns on every record, not slices.
Limitations
Publishers release on different schedules, so the latest period differs by region; compare regions on the same period. Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
Verification
Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.

Sources · 3 documents

Other slices of clinical trial country uses

Frequently asked questions

What is the latest clinical trial country use share?

European Union: 27% in 2025.

Where does this data come from?

From 3 documents published by IQVIA. Every figure on this page links to its record, which preserves the original source evidence.

How often is it updated?

Annual. The newest published period is 2025; the next release should cover 2026. A new figure appears here once the publisher releases it and it passes verification.

Can I use this data?

Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.

Cite this page

Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Clinical trial country use share [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/clinical-trial-country-use-share

"Clinical trial country use share." StatOrigin, 2026, https://statorigin.org/indicators/clinical-trial-country-use-share. Accessed 28 Oct. 2026.

StatOrigin. "Clinical trial country use share." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/clinical-trial-country-use-share.

@misc{statorigin_clinical_trial_country_use_share_2026, title = {Clinical trial country use share}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/clinical-trial-country-use-share}, note = {Data set. Accessed 2026-10-28} }